Biogen enhances its portfolio and margins amidst market challenges and competition. Click here to find out why BIIB stock is ...

With its move to MIT’s Volpe Center in Kendall Square, the drugmaker is consolidating its local footprint from three ...

Based on the drug’s list price, the committee found that the ... We are actively engaging with Biogen to discuss how they might address the uncertainties identified by the committee, while ...

We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the ...

Since 2016, the FDA has approved three disease-modifying treatments for spinal muscular atrophy, with several ...

As part of a bid to consolidate its footprint in Massachusetts, Biogen is foregoing its old home base to put down new roots ...

Biogen and Eisai said the European Medicines Agency's Committee for Medicinal Products for Human Use has reaffirmed its recommended approval of their Alzheimer's drug Leqembi. The companies on ...

“We are thrilled to see them begin a new era in our state.” Probably best known for its multiple sclerosis drugs, Biogen has 1,654 employees in Massachusetts and about 7,500 employees ...